26/08/2026
Obesity care extends far beyond the weighing scale—particularly for us in pulmonary and sleep medicine.
The obesity–OSA phenotype represents an important intersection of metabolic dysfunction, upper-airway disease, nocturnal hypoxaemia and cardiometabolic risk. Looking forward to discussing this perspective during the scientific session:
“Base to Peak: Approaching the Obesity Mountain with Tirzepatide.”
An opportunity to understand how meaningful weight management may complement our conventional approach to obesity-related sleep apnoea.
26 August 2026
Jaipur